Your session is about to expire
← Back to Search
Warnings for Tobacco Use
N/A
Recruiting
Led By Adam O Goldstein
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Over 21 years old
Do not have any eye conditions that prevent them from being eye tracked (e.g., glaucoma, lazy eye, bifocals)
Must not have
Unable to come to an appointment
Under 21 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see how removing flavor descriptions from little cigar and cigarillo packaging affects how people pay attention to health warnings and how they feel about the products. The study will use eye tracking, skin
Who is the study for?
This trial is for individuals who use tobacco products. Participants will be involved in a study that uses eye tracking and other measures to see how they react to different types of warnings on little cigar and cigarillo packages.
What is being tested?
The study is testing reactions to four combinations of package warnings: pictures with no flavor, text-only with 'sweet' flavor, text-only with no flavor, and pictures with 'sweet' flavor. The goal is to understand the impact on attention and feelings towards these warnings.
What are the potential side effects?
There are generally no direct side effects from participating in this type of behavioral study as it involves observation through eye-tracking and response measurements rather than medical interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 21 years old.
Select...
I do not have eye conditions like glaucoma or lazy eye that affect tracking.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot attend an in-person appointment.
Select...
I am younger than 21 years old.
Select...
I do not speak English.
Select...
I do not have eye conditions like glaucoma or lazy eye that prevent tracking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Attention to flavor area of interest
Attention to warning areas of interest
Secondary study objectives
Affective response to warnings
Electrodermal activity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: LCC Package with text-only warning and no flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with text-only warnings and no flavor descriptor.
Group II: LCC Package with text-only warning and 'sweet' flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with text-only warnings and a 'sweet' flavor descriptor
Group III: LCC Package with pictorial warning and no flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with pictorial warnings and no flavor descriptor.
Group IV: LCC Package with pictorial warning and 'sweet' flavorExperimental Treatment1 Intervention
Participants will see a mock LCC package with pictorial warnings and a 'sweet' flavor descriptor.
Find a Location
Who is running the clinical trial?
Food and Drug Administration (FDA)FED
181 Previous Clinical Trials
1,548,549 Total Patients Enrolled
4 Trials studying Tobacco Use
912 Patients Enrolled for Tobacco Use
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,480 Total Patients Enrolled
19 Trials studying Tobacco Use
10,485 Patients Enrolled for Tobacco Use
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
365 Previous Clinical Trials
92,620 Total Patients Enrolled
1 Trials studying Tobacco Use
1,029 Patients Enrolled for Tobacco Use
Adam O GoldsteinPrincipal InvestigatorUNC Lineberger Comprehensive Cancer Center
1 Previous Clinical Trials
1,029 Total Patients Enrolled
1 Trials studying Tobacco Use
1,029 Patients Enrolled for Tobacco Use